Credit Suisse’s Burning Rock Biotech BNR Stock Holding History

Credit Suisse’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-682	Closed	-$16K	–	3963
2022 Q3	$16K	Sell	682 -82,655	-99%	-$2.67M	﹤0.01%	3597
2022 Q2	$2.42M	Buy	+83,337	New	+$3.72M	﹤0.01%	1776
2021 Q4	–	Sell	-6,196	Closed	-$1.11M	–	4505
2021 Q3	$1.11M	Buy	6,196 +1,588	+34%	+$353K	﹤0.01%	3258
2021 Q2	$1.36M	Buy	+4,608	New	+$1.36M	﹤0.01%	3155

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Credit Suisse's BNR Position: Q4 2022 in Review

Credit Suisse sold out of Burning Rock Biotech (BNR) in Q4 2022, closing a stake of 682 shares — an estimated $16K sold.

Credit Suisse first reported a position in BNR in Q2 2021 and held it in 4 quarters. The position peaked at $2.42M in Q2 2022. 42 funds tracked by Wall St. Rank hold BNR as of Q4 2022.

Credit Suisse reported no remaining Burning Rock Biotech position as of Q4 2022 after selling out during the quarter.
Credit Suisse sold 682 Burning Rock Biotech shares in Q4 2022, an estimated $16K.
Credit Suisse first reported a position in Burning Rock Biotech in Q2 2021 and held it in 4 quarters.
Credit Suisse's Burning Rock Biotech position peaked at $2.42M in Q2 2022.
42 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.